← FDA Drug Approvals (Drugs@FDA)

NABUMETONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2019-08-30

Drug application

FDA Application #

ANDA203166

Application type

Abbreviated New Drug Application (Generic)

Brand name

NABUMETONE

Generic name

NABUMETONE

Active ingredients

NABUMETONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

LGM PHARMA

Manufacturer

Carwin Pharmaceutical Associates, LLC

First approval

2019-08-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown